Company intelligence / Profile preview

LightBox Science

Ownership: Private
Development stage: Preclinical

Overview

LightBox Science has over a decade of experience in cancer biomarker detection. The company recently shifted from using third-party technologies to developing its own proprietary platform—LightBOX—for automated point-of-care capture, staining, and imaging of circulating tumor cells from blood samples. Their R&D is focused on improving early cancer screening through advanced biomarker analysis. No published results from large-scale clinical trials are mentioned.

Therapeutic areas: Oncology
Modalities: Biomarker detectionCirculating tumor cell (CTC) capture and analysis
Industry: Pathology

Beyond the preview

Go deeper on LightBox Science.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on LightBox Science.

Explore the full profile